The head of the WHO European Office: “I hope the process of registration of Sputnik will be completed soon” The pandemic will end when 70% of the world's population is vaccinated and medicines are developed to treat those who fall ill, said the head of the WHO European Office. According to him, “Sputnik V” will soon receive registration of the organization
The process of registration of the Russian vaccine Sputnik V The World Health Organization (WHO) will soon be completed, said the head of the organization's Regional Office for Europe, Hans Kluge.
In an interview with TASS, he said that the Russian Direct Investment Fund (RDIF) in October signed all the legal agreements required to be included in the Emergency Use Listing (EUL) list, after which WHO held a meeting with the fund. discussed what data the organization lacks to complete the procedure.
The company has pledged to provide a detailed roadmap for data reporting so that WHO can expedite the evaluation of this vaccine. The submission is expected by the end of December 2021 and I hope that the process will be completed shortly thereafter. '', & Mdash; said Kluge.
RBC sent a request to RDIF.
According to him, the approval of the Russian vaccine & mdash; non-political process: it is now important to vaccinate as many people around the world as possible to stop the pandemic.
“ The pandemic will end when we can vaccinate 70% of the world's population. It will end when we can develop effective and safe antiviral drugs for treating people infected with COVID-19 '', & mdash; says the head of the WHO European Office.
It is also necessary to strengthen health systems, train future health workers in other pandemics and interact not as separate nation states, but “ as one family. '' “ It will end when everyone, without exception, is armed with science and takes responsibility for their actions, '' & mdash; Kluge stated.
Application for accelerated registration and retraining of Sputnik V RDIF filed with WHO at the end of October 2020.
In June, WHO published a report on the audit of four Russian enterprises that manufacture Sputnik V. The report said that the organization had comments on the work of the enterprise OJSC Pharmstandard & mdash; Ufa Vitamin Plant '', located in Bashkiria, which concerned compliance with the production standards of the drug.
On the same day, the press secretary of the Russian president, Dmitry Peskov, said that all the shortcomings identified by the WHO inspectors had been corrected. However, in September it became known that due to this, the approval process for Sputnik V was suspended, it was resumed in October. Before that, the head of the Ministry of Health Mikhail Murashko met with WHO Director General Tedros Ghebreyesus, they discussed, among other things, the procedure for approving the vaccine. According to the minister, during the meeting of this meeting, all issues related to the registration of Sputnik V were resolved.
After that, Kluge said that WHO could approve Sputnik V; in the first quarter of 2022. WHO also announced the timing of inspections at Russian factories for the production of the Sputnik V vaccine. According to Rogerio Gaspar, Director of the Department for Retraining and Circulation of Medicines at WHO, the organization may re-inspect factories as early as February next year.
Subscribe to FB RBC Receive news faster than anyone